MX2007014222A - Uso de acido adamantil metoxidifenil propenoico para el tratamiento del acne. - Google Patents

Uso de acido adamantil metoxidifenil propenoico para el tratamiento del acne.

Info

Publication number
MX2007014222A
MX2007014222A MX2007014222A MX2007014222A MX2007014222A MX 2007014222 A MX2007014222 A MX 2007014222A MX 2007014222 A MX2007014222 A MX 2007014222A MX 2007014222 A MX2007014222 A MX 2007014222A MX 2007014222 A MX2007014222 A MX 2007014222A
Authority
MX
Mexico
Prior art keywords
acne
treatment
mice
gel
propenoic acid
Prior art date
Application number
MX2007014222A
Other languages
English (en)
Spanish (es)
Inventor
Claudio Pisano
Loredana Vesci
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of MX2007014222A publication Critical patent/MX2007014222A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
MX2007014222A 2005-05-20 2006-05-05 Uso de acido adamantil metoxidifenil propenoico para el tratamiento del acne. MX2007014222A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000248A ITRM20050248A1 (it) 2005-05-20 2005-05-20 Uso acido adamantil metossidifenil propenoico per il trattamento di patologie cutanee.
PCT/EP2006/062088 WO2006122883A1 (en) 2005-05-20 2006-05-05 Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne

Publications (1)

Publication Number Publication Date
MX2007014222A true MX2007014222A (es) 2008-02-07

Family

ID=36646157

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007014222A MX2007014222A (es) 2005-05-20 2006-05-05 Uso de acido adamantil metoxidifenil propenoico para el tratamiento del acne.

Country Status (13)

Country Link
US (1) US7635719B2 (enExample)
EP (1) EP1890671B1 (enExample)
JP (1) JP5072833B2 (enExample)
KR (1) KR101307910B1 (enExample)
CN (1) CN101180028B (enExample)
AR (1) AR054361A1 (enExample)
AU (1) AU2006248981B2 (enExample)
BR (1) BRPI0611289A2 (enExample)
CA (1) CA2606567A1 (enExample)
IT (1) ITRM20050248A1 (enExample)
MX (1) MX2007014222A (enExample)
TW (1) TWI365753B (enExample)
WO (1) WO2006122883A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5109383B2 (ja) * 2007-01-31 2012-12-26 大正製薬株式会社 アダパレン含有外用剤組成物
JP2009137874A (ja) * 2007-12-05 2009-06-25 Authele:Kk ビタミンＣ（Ａｓｃｏｒｂｉｃａｃｉｄ）を含有するレシチンゲルおよびその製造方法
TW201031402A (en) * 2008-12-24 2010-09-01 Sigma Tau Ind Farmaceuti New retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
EP3301085A1 (en) * 2016-09-29 2018-04-04 Biogem S.Ca.R.L. Retinoid derivatives with antitumor activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071923A (en) * 1994-09-16 2000-06-06 Bar-Ilan University Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases
FR2752734B1 (fr) * 1996-09-02 1998-11-06 Cird Galderma Utilisation de retinoides pour la preparation d'un medicament destine a traiter les affections liees a une surexpression de vegf
US5994330A (en) * 1998-11-09 1999-11-30 El Khoury; Georges F. Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
ITRM20010464A1 (it) * 2001-07-31 2003-01-31 Sigma Tau Ind Farmaceuti Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
WO2003075908A1 (en) * 2002-03-12 2003-09-18 Galderma Research & Development, S.N.C. Use of adapalene for the treatment of dermatological disorders

Also Published As

Publication number Publication date
AU2006248981A1 (en) 2006-11-23
WO2006122883A1 (en) 2006-11-23
TW200716192A (en) 2007-05-01
KR20080016573A (ko) 2008-02-21
US20080153916A1 (en) 2008-06-26
CN101180028A (zh) 2008-05-14
US7635719B2 (en) 2009-12-22
WO2006122883A9 (en) 2012-10-04
ITRM20050248A1 (it) 2006-11-21
HK1117737A1 (en) 2009-01-23
EP1890671A1 (en) 2008-02-27
KR101307910B1 (ko) 2013-09-16
CN101180028B (zh) 2010-12-08
AR054361A1 (es) 2007-06-20
JP2008540603A (ja) 2008-11-20
AU2006248981B2 (en) 2011-06-02
BRPI0611289A2 (pt) 2010-08-31
CA2606567A1 (en) 2006-11-23
JP5072833B2 (ja) 2012-11-14
EP1890671B1 (en) 2014-03-05
TWI365753B (en) 2012-06-11

Similar Documents

Publication Publication Date Title
JP6818792B2 (ja) メラニン改変組成物および使用方法
RU2377981C1 (ru) Применение 6-[3-(1-адамантил)-4-метоксифенил]-2-нафтойной кислоты для лечения дерматологических расстройств
US20030064969A1 (en) Novel compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
KR101018352B1 (ko) 봉독을 유효성분으로 하는 여드름 예방 및 치료용 조성물
KR102632946B1 (ko) 노화 방지 및 피부 톤 미백 조성물 및 이를 위한 방법
HK59493A (en) Dermatological, pharmaceutical or cosmetic composition consisting of hydrated lipid lamellar phases or liposomes and containing retinoids or analogues such as carotenoids
JP3827195B2 (ja) 消炎鎮痛剤
CN1255053A (zh) 抗坏血酸基－磷酰基－胆固醇
KR20010034857A (ko) 피부질환 예방 및 치료제
JP5732471B2 (ja) 溶媒混合物およびビタミンｄ誘導体から成る医薬品組成物または類似体
Rigopoulos et al. Comparison of topical retinoids in the treatment of acne
JP2022511270A (ja) シロリムス含有組成物
HK1223297A1 (en) Topical retinoid solutions
AU2006248981B2 (en) Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne
RU2450836C1 (ru) Комбинированная мазевая композиция для уменьшения интенсивности локальной гиперпигментации кожи
HK1117737B (en) Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne
US10022348B2 (en) Topical solution of isotretinoin
JP2014144929A (ja) ビタミン類を含有するニキビの予防又は治療用組成物
Naudé Formulation, in vitro release and transdermal diffusion of Vitamin A and Zinc for the treatment of acne
MICHELLE et al. Skin Barrier Repair
Cunliffe Vitamin a in Dermatology
WO2021189077A1 (en) Methods for treating acne

Legal Events

Date Code Title Description
FG Grant or registration